<DOC>
	<DOCNO>NCT00450710</DOCNO>
	<brief_summary>Evaluation determine safety two laparoscopic procedure control T2DM .</brief_summary>
	<brief_title>Neuroendocrine Brake Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Male female 18 65 year . 2 . BMI 25.1 34.9 . 3 . Type 2 diabetic patient oral antidiabetic agent and/or insulin treatment minimum 12 month prior enrollment . 4 . Diagnosis T2DM least 3 year . 5 . Patient routine care hte study physician another physician supply reliable medical record least 3 year . 6 . HbA1c &gt; / 7.5 document least 3 month . 7 . Stable weight ( significant weight change ( &gt; 3 % ) 3 month prior enrollment . 8 . Stable medication least one month prior enrollment except diabetes medication stable least 3 month prior enrollment . 9 . Ability willingness return schedule visit participate recommend parameter set physician recommend medical/laboratory assessment . 1 . Prior abdominal surgery , except laparoscopic cholecystectomy . 2 . Taking appetite suppressant . 3 . Severe eat disorder . 4 . Severe pulmonary , renal cardiac disease . 5 . Obese due clinically diagnosed endocrine disorder . 6 . Subjects impair liver function . 7 . History peptic ulcer disease . 8 . History malignant disease . 9 . Use prescription , counter herbal weight loss product . 10 . Pregnant planning pregnancy enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>